Royal Bank of Canada’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Royal Bank of Canada’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,000	Closed	-$41K	–	7448
2018 Q4	$41K	Hold	3,000	–	–	﹤0.01%	5213
2018 Q3	$33K	Buy	+3,000	New	+$30K	﹤0.01%	5439
2017 Q1	–	Sell	-3,876	Closed	-$18K	–	7089
2016 Q4	$18K	Buy	3,876 +3,376	+675%	+$17.3K	﹤0.01%	5847
2016 Q3	$2K	Hold	500	–	–	﹤0.01%	6238
2016 Q2	$3K	Hold	500	–	–	﹤0.01%	6115
2016 Q1	$3K	Sell	500 -51	-9%	-$356	﹤0.01%	6101
2015 Q4	$6K	Sell	551 -1,968	-78%	-$26.7K	﹤0.01%	6134
2015 Q3	$46K	Sell	2,519 -418	-14%	-$8.07K	﹤0.01%	5183
2015 Q2	$57K	Buy	2,937 +1,782	+154%	+$31.5K	﹤0.01%	5160
2015 Q1	$20K	Buy	+1,155	New	+$19.4K	﹤0.01%	5368
2013 Q4	–	Sell	-186	Closed	-$3K	–	6589
2013 Q3	$3K	Buy	+186	New	+$2.75K	﹤0.01%	5834

Other funds holding OSIR

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CCM

Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Royal Bank of Canada's OSIR Position: Q1 2019 in Review

Royal Bank of Canada sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2019, closing a stake of 3,000 shares — an estimated $41K sold.

Royal Bank of Canada first reported a position in OSIR in Q3 2013 and held it in 11 quarters. The position peaked at $57K in Q2 2015. 57 funds tracked by Wall St. Rank hold OSIR as of Q1 2019.

Royal Bank of Canada reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Royal Bank of Canada sold 3,000 Osiris Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $41K.
Royal Bank of Canada first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 11 quarters.
Royal Bank of Canada's Osiris Therapeutics, Inc. Common Stock position peaked at $57K in Q2 2015.
57 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Royal Bank of Canada's 13F filing for Q1 2019, filed 15 May 2019.